Bladder cancer typically originates in the cells that line the interior of the bladder. Because most cases are diagnosed at an early stage, bladder cancer is considered highly treatable. Risk for developing cancer is increased with smoking, age, exposure to certain chemicals, certain diabetes medications, and frequent bladder inflammations. However, bladder cancer is most common in white men. Treatments for bladder cancer include surgery, immunotherapy, chemotherapy, and radiation therapy. Bladder cancer is divided into four stages that determine the severity of the cancer as well as the best course of treatment for the cancer in that stage. Many of these stages have subgroups that further assist in classifying the cancer and its progression.
Stage, Bladder Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage, Bladder Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1618 products for the study of Stage, Bladder Cancer that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.